December 2008 Oncology News International

News
Article

Cover Story

Clara Bloomfield: Buck conventional wisdom always

New breast cancer program reduces time to treatment

ACS expert warns that global burden of cancer will skyrocket without prevention

DEPARTMENTS

Focus on Hematology

CyBorD combo supports stem cell collection in newly diagnosed multiple myeloma

Vantage Point: Rate of response to CyBorD is 'truly remarkable'

Focus on Lung Cancer

Final AVAiL results confirm longer PFS with bevacizumab

Focus on Colon Cancer

New presurgical strategies render colon mets resectable

Vantage Point: Converting unresectable to resectable: Data still limited

Focus on Breast Cancer

Brachytherapy improves treatment in augmented women

Recent Videos
Retrospective and real-world registry studies may be necessary to guide clinical decision-making for rarer lymphomas with insufficient prospective data.
Extravasation results in exposing healthy tissue to radiation, which can be highly dosed depending on the isotope used for treatment.
4 experts in this video
2 experts in this video
2 experts in this video
4 experts in this video
Ongoing studies seek to evaluate immunotherapy in earlier lines of therapy for patients with early-stage Hodgkin lymphoma.
Strict inclusion criteria may disproportionately exclude racial minority populations from participating in breast cancer trials.
Related Content